There are currently 11 ongoing clinical trials involving Achondroplasia
Of the 11 trials,8 trials are in Phase II
Furthermore, 2 trials are in Phase I
The global pharmaceutical industry is steadily developing new drugs for Achondroplasia, a Musculoskeletal disorder. Asia-pacific boasts the highest number of ongoing clinical trials involving Achondroplasia. Europe and North America are among some of the other prominent regions involved in Achondroplasia-related drug trials.
BioMarin Pharmaceutical: The leading ongoing Achondroplasia related clinical trial sponsor
BioMarin Pharmaceutical, the United States of America-based pharmaceutical company, is the top sponsor for Achondroplasia-related ongoing clinical trials.
Pfizer, Nagoya University Hospital, Ascendis Pharma, QED Therapeutics, and Sanofi are a few other notable sponsors involving Achondroplasia. A clinical trial sponsor can be a Company, Government, Individual, or Institution.
Marketed Drugs involving Achondroplasia
Vosoritide (voxzogo) and Somatropin (ansomone) are among the key marketeddrugs involving Achondroplasia.
Vosoritide (voxzogo), an Atrial Natriuretic Peptide Receptor 2 (Atrial Natriuretic Peptide Receptor Type B or Guanylate Cyclase B or NPR2 or EC 4.6.1.2) Agonist drug, is used to treat Achondroplasia and Dwarfism, a Hormonal Disorder. The drug is marketed in the United States of America, Austria, Belgium, Denmark, and the European Union by BioMarin Pharmaceutical. Voxzogo (vosoritide) was first approved in 2021 and is sold in powdered form and administered in solution form through subcutaneous injection.
Somatropin (ansomone), a Growth Hormone Receptor (Somatotropin Receptor or GHR) Agonist drug, is used to treat Achondroplasia, Burns, Growth Hormone Deficiency, Idiopathic Short Stature, Noonan Syndrome, Short Bowel Syndrome, and Shox Deficiency. The drug is sold in China by Anhui Anke Biotechnology (Group). Ansomone(somatropin) was first approved in 2015 and is sold in powdered form and administered in solution form through subcutaneous injection.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward